000			02016 a2200589 4500
005			20250516095907.0
264		0	_c20130619
008			201306s 0 0 eng d
022			_a1476-5594
024	7		_a10.1038/onc.2012.246 _2doi
040			_aNLM _beng _cNLM
100	1		_aGómez-Casares, M T
245	0	0	_aMYC antagonizes the differentiation induced by imatinib in chronic myeloid leukemia cells through downregulation of p27(KIP1.). _h[electronic resource]
260			_bOncogene _cApr 2013
300			_a2239-46 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aBenzamides _xpharmacology
650	0	4	_aCell Differentiation
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation
650	0	4	_aCyclin-Dependent Kinase Inhibitor p27 _xgenetics
650	0	4	_aDasatinib
650	0	4	_aDown-Regulation
650	0	4	_aErythroid Cells _xdrug effects
650	0	4	_aGene Expression
650	0	4	_aGene Expression Regulation, Leukemic
650	0	4	_aHumans
650	0	4	_aImatinib Mesylate
650	0	4	_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
650	0	4	_aPiperazines _xpharmacology
650	0	4	_aProto-Oncogene Proteins c-myc _xphysiology
650	0	4	_aPyrimidines _xpharmacology
650	0	4	_aS-Phase Kinase-Associated Proteins _xmetabolism
650	0	4	_aThiazoles _xpharmacology
650	0	4	_abeta-Globins _xgenetics
700	1		_aGarcía-Alegria, E
700	1		_aLópez-Jorge, C E
700	1		_aFerrándiz, N
700	1		_aBlanco, R
700	1		_aAlvarez, S
700	1		_aVaqué, J P
700	1		_aBretones, G
700	1		_aCaraballo, J M
700	1		_aSánchez-Bailón, P
700	1		_aDelgado, M D
700	1		_aMartín-Perez, J
700	1		_aCigudosa, J C
700	1		_aLeón, J
773	0		_tOncogene _gvol. 32 _gno. 17 _gp. 2239-46
856	4	0	_uhttps://doi.org/10.1038/onc.2012.246 _zAvailable from publisher's website
999			_c21875488 _d21875488